Sanofi India
BSE: 500674 | NSE: SANOFI | ISIN: INE058A01010 | SECTOR: Biotechnology & DrugsOpen
8,470.70High
8,470.70Low
8,240.00Prev Close
8,470.70P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
190.84BVolume
0.72KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
500674NSE
SANOFIISIN
INE058A01010
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
Company Officers
Rachid Ayari
Chief Financial Officer, Whole-time DirectorRadhika Shah
Compliance Officer, Company Secretary, Head of LegalRodolfo Hrosz
Managing Director, Whole Time DirectorRenee Amonkar
Additional Whole Time DirectorBratin Bag
Senior Director - Ethics and Business Integrity, South AsiaSurabhi Kaul
India People DirectorShalini Menon
General Medicines Medical Head - India, India Medical LeadYasmin Shenoy
Senior Director - Regulatory AffairsAparna Thomas
Senior Director - Corporate Communications and Corporate Social Responsibility, India and South AsiaLinumon Thomas
Digital Leader, India